O-02 Phase 3 PRISM trials : Update on pegvaliase treatment efficacy and safety for adult phenylketonuria ○

Mitsuhiro Kuwahara,Cary O. Harding,Deborah Bilder,John Posner,Harvey Levy,Orli Rosen,Mingjin Li,Joy Olbertz,Haoling H Weng

semanticscholar（2019）

引用 0|浏览8

暂无评分

摘要

O-02 Phase 3 PRISM trials: Update on pegvaliase treatment efficacy and safety for adult phenylketonuria ○ Mitsuhiro Kuwahara1, Cary O. Harding2, Deborah Bilder3, John Posner4, Harvey Levy5, Orli Rosen6 Mingjin Li6, Joy Olbertz6, Haoling H Weng6 1BioMarin Pharmaceutical Japan K.K. 2Oregon Health & Science University, Portland, OR, USA 3University of Utah, Salt Lake City, UT, USA 4King’s College London, London, UK 5Boston Children’s Hospital, Boston, MA, USA 6BioMarin Pharmaceutical Inc., Novato, CA, USA

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要